193 studies found for:    abacavir OR Abacavir/ Lamivudina/ Zidovudina [TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Completed
Has Results
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
Condition: HIV Infection
Interventions: Other: Intervention 1: PK assessment while on Twice Daily Abacavir;   Other: Intervention 2: PK assessment while on Once Daily Abacavir
2 Active, not recruiting Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
Condition: Psoriasis
Interventions: Drug: Prurisol;   Drug: Ziagen
3 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
4 Completed Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
Condition: HIV
Interventions: Drug: Abacavir;   Drug: Darunavir/ritonavir;   Drug: Raltegravir
5 Recruiting Tenofovir Abacavir Platelet Activation Study
Condition: HIV
Interventions: Drug: abacavir (600 mg QD);   Drug: tenofovir (245 mg QD)
6 Completed
Has Results
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
Condition: Human Immunodeficiency Virus
Interventions: Other: Clinically Driven Monitoring (CDM);   Other: Laboratory plus Clinical Monitoring (LCM);   Drug: Arm A: ABC+3TC+NNRTI;   Drug: Arm B: ZDV+ABC+3TC+NNRTI->ABC+3TC+NNRTI maintenance;   Drug: Arm C: ZDV+ABC+3TC+NNRTI->ZDV+ABC+3TC maintenance;   Drug: Once-daily ABC+3TC;   Drug: Twice-daily ABC+3TC;   Drug: Continued cotrimoxazole prophylaxis;   Other: Stopped cotrimoxazole prophylaxis
7 Recruiting ZIAGEN® Post-marketing Surveillance
Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
8 Not yet recruiting Determining the Effect of Abacavir on Platelet Activation
Conditions: HIV;   Cardiovascular Disease
Intervention: Drug: Abacavir
9 Completed
Has Results
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Condition: HIV Infection
Interventions: Drug: emtricitabine/tenofovir;   Drug: abacavir/lamivudine
10 Completed Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
Condition: HIV Infection
Intervention: Drug: abacavir
11 Completed Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
Condition: HIV Infection
Intervention: Drug: Abacavir
12 Completed
Has Results
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
13 Completed Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density
Condition: HIV
Intervention: Drug: Switch from tenofovir to abacavir
14 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
15 Terminated Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Amprenavir;   Drug: Abacavir
16 Recruiting Abacavir and Lamivudine PK in Children
Condition: HIV
Interventions: Drug: abacavir;   Drug: 3TC
17 Unknown  Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
18 Completed A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Condition: HIV Infection
Intervention: Drug: Abacavir/Lamivudine
19 Completed Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: Abacavir+lamivudine
20 Active, not recruiting
Has Results
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: Dolutegravir;   Drug: Atripla;   Drug: Abacavir/Lamivudine;   Drug: Abacavir/Lamivudine Placebo;   Drug: Dolutegravir placebo;   Drug: Atripla placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years